secwatch / observer
8-K filed June 1, 2023, 7:59 PM ET ticker BLCO CIK 0001860742
leadership confidence high sentiment neutral materiality 0.60

Bausch + Lomb reshapes exec team; Gordon becomes advisor, business unit heads elevated

Bausch & Lomb Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joseph F. Gordon

strategic advisor
BLCO · Bausch & Lomb Corp
Effective
2023-06-01
Filed
June 1, 2023, 7:59 PM ET
Joseph F. Gordon will transition from his current role as President, Global Consumer, Surgical and Vision Care to the new role of strategic advisor to the Chairman and Chief Executive Officer of the Company, effective June 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph F. Gordon changed role as strategic advisor at Bausch & Lomb Corp.

Action
transitioned
Role
strategic advisor
Exact text from the filing
Joseph F. Gordon will transition from his current role as President, Global Consumer, Surgical and Vision Care to the new role of strategic advisor to the Chairman and Chief Executive Officer of the Company, effective June 1, 2023.
View on SEC.gov

Bausch & Lomb Corp filing history →

Source: SEC EDGAR
accession 0000950103-23-008261
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.